The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer.
Boscolo Bielo L, Trapani D, Nicolò E, Valenza C, Guidi L, Belli C, Kotteas E, Marra A, Prat A, Fusco N, Criscitiello C, Burstein HJ, Curigliano G.
Boscolo Bielo L, et al. Among authors: guidi l.
Cancer Treat Rev. 2024 May 16;128:102761. doi: 10.1016/j.ctrv.2024.102761. Online ahead of print.
Cancer Treat Rev. 2024.
PMID: 38772169
Review.